Migden, M.; Lear, J.; Squittieri, N.; Liu, L.; Guminski, A.; Dummer, R. Duration of Response and Progression-Free Survival With Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients With Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind. J of Skin 2020, 4, s68.